More Evidence on the Impact of India's Conditional Cash Transfer Program, Janani Suraksha Yojana: Quasi-Experimental Evaluation of the Effects on Childhood Immunization and Other Reproductive and Child Health Outcomes by Carvalho, Natalie et al.
 
More Evidence on the Impact of India's Conditional Cash Transfer
Program, Janani Suraksha Yojana: Quasi-Experimental Evaluation
of the Effects on Childhood Immunization and Other Reproductive
and Child Health Outcomes
 
 
(Article begins on next page)
The Harvard community has made this article openly available.
Please share how this access benefits you. Your story matters.
Citation Carvalho, Natalie, Naveen Thacker, Subodh S. Gupta, and Joshua
A. Salomon. 2014. “More Evidence on the Impact of India's
Conditional Cash Transfer Program, Janani Suraksha Yojana:
Quasi-Experimental Evaluation of the Effects on Childhood
Immunization and Other Reproductive and Child Health
Outcomes.” PLoS ONE 9 (10): e109311.
doi:10.1371/journal.pone.0109311.
http://dx.doi.org/10.1371/journal.pone.0109311.
Published Version doi:10.1371/journal.pone.0109311
Accessed February 17, 2015 3:00:41 AM EST
Citable Link http://nrs.harvard.edu/urn-3:HUL.InstRepos:13347453
Terms of Use This article was downloaded from Harvard University's DASH
repository, and is made available under the terms and conditions
applicable to Other Posted Material, as set forth at
http://nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of-
use#LAAMore Evidence on the Impact of India’s Conditional Cash
Transfer Program, Janani Suraksha Yojana: Quasi-
Experimental Evaluation of the Effects on Childhood
Immunization and Other Reproductive and Child Health
Outcomes
Natalie Carvalho
1,2*, Naveen Thacker
3, Subodh S. Gupta
4, Joshua A. Salomon
2,5
1Global Burden of Disease Group and Center for Health Policy, Melbourne School of Population and Global Health, Melbourne, Australia, 2Center for Health Decision
Sciences, Harvard School of Public Health, Boston, Massachusetts, United States of America, 3Deep Children Hospital and Research Centre, Gandhidham, Gujarat, India,
4Department of Community Medicine, Mahatma Gandhi Institute of Medical Sciences, Sewagram, Maharashtra, India, 5Department of Global Health and Population,
Harvard School of Public Health, Boston, Massachusetts, United States of America
Abstract
Background: In 2005, India established a conditional cash transfer program called Janani Suraksha Yojana (JSY), to increase
institutional delivery and encourage the use of reproductive and child health-related services.
Objective: To assess the effect of maternal receipt of financial assistance from JSY on childhood immunizations, post-
partum care, breastfeeding practices, and care-seeking behaviors.
Methods: We use data from the latest district-level household survey (2007–2008) to conduct a propensity score matching
analysis with logistic regression. We conduct the analyses at the national level as well as separately across groups of states
classified as high-focus and non-high-focus. We carry out several sensitivity analyses including a subgroup analysis stratified
by possession of an immunization card.
Results: Receipt of financial assistance from JSY led to an increase in immunization rates ranging from 3.1 (95%CI 2.2–4.0)
percentage points for one dose of polio vaccine to 9.1 (95%CI 7.5–10.7) percentage points in the proportion of fully
vaccinated children. Our findings also indicate JSY led to increased post-partum check-up rates and healthy early
breastfeeding practices around the time of childbirth. No effect of JSY was found on exclusive breastfeeding practices and
care-seeking behaviors. Effect sizes were consistently larger in states identified as being a key focus for the program. In an
analysis stratified by possession of an immunization card, there was little to no effect of JSY among those with vaccination
cards, while the effect size was much larger than the base case results for those missing vaccination cards, across nearly all
immunization outcomes.
Conclusions: Early results suggest the JSY program led to a significant increase in childhood immunization rates and some
healthy reproductive health behaviors, but the structuring of financial incentives to pregnant women and health workers
warrants further review. Causal interpretation of our results relies on the assumption that propensity scores balance
unobservable characteristics.
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Introduction
India has some of the worst maternal and child health indicators
in the world, with approximately 18% of global maternal deaths
and over 20% of all deaths among children under age five
years.[1,2] From 2000 to 2008, India experienced an average
annual decline in under-five mortality rate of 3.9%, with highly
uneven progress across states, and falling short of the 4.4%
reduction per year required to meet the 2015 Millennium
Development Goal (MDG) 4 target.[3,4,5] Since 2008, India has
experienced a higher rate of decline in under-five mortality,[6]
some of which may be attributed to the launch of the national
PLOS ONE | www.plosone.org 1 October 2014 | Volume 9 | Issue 10 | e109311rural health mission in 2005. India now appears much closer to
achieving MDG4, which looked distant a few years ago.
Childhood immunizations are critical to safeguarding child
health. According to the World Health Organization (WHO),
approximately 40% of all under-vaccinated children, defined as
children who did not receive 3 doses of diphtheria, tetanus and
pertussis (DPT) in their first year of life, live in India.[7] Although
immunization rates have increased over time, only slightly more
than half of children nationwide are fully vaccinated, with wide
variations across geographic and socioeconomic strata.[8] Inade-
quate rates of childhood immunization persist despite vaccinations
being provided free of charge in public health facilities through
India’s Universal Immunization Program (UIP), which covers 27
million infants and 30 million pregnant women annually.[9,10]
In 2005, India’s Ministry of Health and Family Welfare
(MOHFW) launched the National Rural Health Mission
(NRHM), which aimed to bring in health sector reforms to
strengthen public health management and ensure effective health
care delivery.[11,12] A key feature of NRHM is a safe
motherhood scheme called Janani Suraksha Yojana (JSY). JSY is
a conditional cash transfer program that provides financial
incentives to pregnant women and female community health
workers to encourage the use of health services during the
antenatal, intrapartum and post-partum period.[11] With a goal of
reducing maternal and childhood mortality, JSY aims to increase
safe deliveries among women of low socioeconomic status by
promoting institutional deliveries, especially in rural areas. The
program operates at the community level through an accredited
social health activist (ASHA) who is selected by NRHM to act as
the intermediary between the women and the state. ASHAs are
responsible for identifying all pregnant women in their community
and facilitating their use of reproductive health services offered by
the state, including antenatal care visits, facility-based delivery,
postnatal checkups, immunization of the newborn, and providing
advice and counseling on breastfeeding practices.[13]
Janani Suraksha Yojana is a national program funded
exclusively by the federal government and managed at the local
level by states.[14,15] Eligibility criteria and financial incentives
vary across states, and have been modified over time. In ten Low
Performing States (LPS) (Assam, Bihar, Chhattisgarh, Jammu and
Kashmir, Jharkhand, Madhya Pradesh, Orissa, Uttarakhand, and
Uttar Pradesh) with low rates of institutional deliveries, all women
are eligible for the program. These states also tend to have higher
fertility rates and worse maternal and child health indicators
compared to the rest of the country.[14] Among the other High
Performing States (HPS), eligibility is restricted to marginalized
women (those with a government-issued below the poverty line
(BPL) card or belonging to a scheduled caste or tribe), and only for
their first two births.[15] Eligible women receive cash assistance
ranging from 600 Indian rupees (Rs.) (,US $10 as of 2014) in
urban areas of HPS to 1,400 Rs. (,US $23) in rural areas of LPS
upon delivering in an accredited facility.[15] BPL women continue
to receive 500 Rs. (,US $8) for deliveries outside of health
facilities for their first two births.[16]
Previous studies have shown that JSY led to increased
institutional deliveries.[15,17,18] An impact evaluation carried
out across all states and union territories (UTs) using three
different analytical approaches found a small but significant effect
of JSY on increasing antenatal care and reducing perinatal and
neonatal mortality among two of three analytic approaches.[17] A
more recent impact evaluation, carried out using the same data,
found little to no impact of JSY on antenatal care and did not find
a significant impact on neonatal and perinatal mortality.[18]
Among other methodological differences between the two studies,
the latter’s differences-in-differences analysis accounts for hetero-
geneity in timing of the introduction of JSY across districts, in
order to control for potential unobserved district-level confound-
ers.[18] Mazumdar and colleagues’ preferred estimates were able
to statistically rule out a reduction in neonatal mortality of greater
than 8.7 deaths per 1,000 live births.[18] In comparison, estimates
of the effect of JSY from a matching analysis by Lim et al.
indicated a reduction of 2.3 neonatal deaths per 1,000 live
births.[17] Lim’s district-level differences-in-differences estimates
of the effect of JSY on health outcomes showed no statistically
significant effect on neonatal or early neonatal mortality.[17]
However, Lim and colleagues note that this analysis may not have
been powered to detect the reduction in perinatal and neonatal
mortality found through their other analytical approaches.[17]
While childhood vaccinations were not the main target of JSY,
the program could have had a direct or indirect effect on these
outcomes. Early guidelines indicated minimum payments to
ASHAs per in-facility delivery of 200 Rs. (,US $3) in urban
areas and 600 Rs. in rural areas of LPS, north-east states, and
tribal areas, with disbursement provided in two payments, the first
upon reaching the institution along with the expectant mother, the
second after making a postnatal visit and the child has been
immunized with the bacillus Calmette-Guerin vaccine (BCG).[16]
More recent government documents indicate financial incentives
provided to ASHAs upon (1) motivating women to seek
institutional delivery and antenatal care, (2) payment for transport
of the pregnant woman to a facility, and (3) escort of the pregnant
woman to the institution.[19] Aside from incentives, increased
interaction with the health system through institutional deliveries
could indirectly lead to an increase in childhood immunizations.
Although there is some evidence that immunization rates have
increased following the start of JSY, there has been no formal
evaluation of the impact of JSY on childhood immunization
rates.[15,20] Prior studies evaluating the effect of conditional cash
transfers on immunization coverage have generally found minimal
improvements in vaccination coverage or non-significant re-
sults.[21] The majority of evidence comes from Latin America,
and in most study areas, vaccination coverage was high prior to
the program’s start. A recent study of cluster randomized
controlled campaigns in a setting with low immunization coverage
in India found that providing small non-financial incentives with
improvements in the reliability of services led to a large increase in
immunization rates, at a cost of approximately $17.35 per
child.[22]
This study evaluates the impact of JSY on childhood
immunization rates in India. Using a quasi-experimental analytic
design, we compared childhood immunization outcomes among
women who had received financial assistance from JSY compared
to those who had not, controlling for possible confounders. We
also evaluated the impact of the program on a range of secondary
outcomes, including receipt of postnatal care, breastfeeding
practices, and care-seeking behavior in the post-natal period,
using the same approach.
Methods
Study design and participants
We conduct a multivariable logistic regression, with matching to
control for confounding, to compute the average effect of JSY on
reproductive and childhood outcomes. Many of the analyses were
modeled after the matching analytical approach used by Lim et
al.[17]
Data used were from the most recent round of the District Level
Household Survey (DLHS-3), one of the largest demographic and
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survey designed primarily to provide estimates of reproductive and
child health indicators.[8] The survey was carried out across 34
states and union territories in India (excluding Nagaland) from
December 2007 to December 2008. Using a multi-stage stratified
sampling design, interviewers collected data from 720,320
households across urban and rural areas of 601 districts in the
country.[8] For households in rural areas, a village-level question-
naire covering 22,825 villages was used to gather information on
village characteristics. We used responses from currently married
women aged 15–44 years who reported having had a live birth
within the period covered by the survey (from January 1, 2004
onwards).
In analyses on postnatal care, breastfeeding practices, and care-
seeking behaviors, data were restricted to children born within the
last 12 months before the survey, to obtain the most recent sample,
and to reduce the effect of varying fertility rates and differential
introduction and scale-up of JSY, on study results.[17,18] For
analyses on immunizations, data were restricted to children 12-23
months of age who were alive at the time of the interview to
prevent premature censuring of vaccine outcomes among children
under 12 months of age.[23]
This study was approved by the Population and Global Health
Human Ethics Advisory Group at the Melbourne School of
Population and Global Health, University of Melbourne.
Study measures
Women were asked whether they had received financial
assistance from JSY for their most recent delivery; those who
responded ‘‘yes’’ to this question were coded as JSY = 1, and
those who responded ‘‘no’’ were coded as JSY = 0. Because
women were only asked about their most recent pregnancy, only
data on women’s most recent live birth could be used to investigate
the effect of JSY on post-delivery indicators and immunization
rates.
Childhood immunization outcomes considered include receiv-
ing the following vaccines: polio at birth (or ‘‘polio zero’’), one dose
of BCG, at least one dose of DPT, three doses of DPT, at least one
dose of polio, three doses of polio, measles, and any hepatitis
B.[24] We also considered the proportion of fully vaccinated
children and children who did not receive any vaccination. In line
with WHO guidelines we defined a fully vaccinated child as one
who had received one dose of BCG vaccine, 3 doses of DPT and
polio vaccines (not including polio at birth), and one dose of
measles vaccine by the age of 12 months.[8,25]
Vaccination status was determined from immunization cards,
supplemented by mothers’ reports where immunization cards were
incomplete or missing. While there are important limitations to
using this type of data, household surveys are regularly used for
estimating childhood immunization rates.[23] For polio at birth,
we include children who had an immunization date for polio zero
in their immunization cards, and those whose mothers reported
them having their first polio vaccine within 2 weeks of birth.
Information on hepatitis B was not included in the immunization
card data; it was the only immunization outcome that relied solely
on maternal reporting. Furthermore, although three doses of
hepatitis B are recommended (similar to DPT and polio),[24] only
one survey question was asked about any hepatitis B vaccination.
Children with missing data (,0.5% of observations) or with a
response of ‘‘don’t know’’ reported for one or more vaccines were
treated as missing observations, and these children were not
included in the denominator. We also considered a more
conservative definition for all vaccines, counting children with
missing vaccination data or ‘‘don’t know’’ responses as not having
been vaccinated; this more conservative definition matched
immunization means reported in the DLHS-3.[8]
Other reproductive and child health indicators included prompt
post-natal check-ups for the mother (within 48 hours of delivery)
and baby (within 24 hours of delivery), three breastfeeding
behavior outcomes (early initiation of breastfeeding within the
first hour of birth, child breastfed colostrum, exclusively breastfed
for 6 months or continuing to be breastfed), and care-seeking
behaviors for symptoms of childhood diarrhea and pneumonia
(sought advice or treatment).
Other measures available from the household survey and
included as covariates in the analysis were measures of household
assets, maternal age and education, information on birth history,
gender of the child, caste or tribe, religion, below-the-poverty-line
card ownership, urban or rural residence, and distance to the
nearest health facility.
Statistical Analysis
We used factor analysis to construct a household wealth index
based on the following categorical household characteristics and
assets: access to an improved drinking water source; access to
improved sanitation; type of house (3 categories, with pucca of
highest quality, kaccha of lowest quality); type of cooking fuel;
access to an electricity connection; presence of other household
assets including fan, television, telephone, scooter and car.
Household wealth quintiles and deciles were generated from this
wealth index.
To investigate the effect of maternal receipt of financial
assistance from JSY on childhood immunization rates and other
reproductive and child health indicators, we conducted a
propensity-score matching (PSM) analysis with logistic regression
to control for potentially confounding differences between the JSY
and non-JSY groups. PSM is a widely used method in impact
evaluation literature when experimental data are not available.
This method can correct for biases in treatment effect due to
observed covariates, that result from confounding due to non-
random assignment of the treatment.[26] Matching allows for the
‘‘treated’’ group to be made as similar to the ‘‘untreated’’ group as
possible based on observed pre-treatment matching covariates, to
reduce the link between the treatment variable (receipt of JSY) and
background characteristics of the participant.[27] In order to draw
causal inferences, this method relies on the assumption that
balancing observables also balances unobservables.
We used a logit model to estimate propensity scores and 1:1
nearest neighbor matching algorithm without replacement to
generate matched groups. Matching covariates included maternal
age, number of live births, birth interval, whether the birth was
part of a multiple birth, maternal education category, household
wealth decile, BPL-card ownership, caste or tribe, religion,
location of residence with respect to distance to the nearest health
facility, and state of residence. We defined categorical variables to
be consistent with the Lim et al. analysis,[17] to facilitate
comparison to prior findings. We performed several PSM
diagnostics including visual inspection of propensity scores in the
treated and control group pre- and post- matching and
comparison of background characteristics between groups pre-
and post-matching. (Figure S1 and Table S1)
The main analysis to identify ‘treatment effects’ for JSY used
logistic regression with state-level fixed effects and robust, clustered
standard errors at the district level. We included the same
regression covariates as in the PSM step. The estimated treatment
effect for a given outcome was obtained using fitted probabilities,
by computing the difference between the probability of the
outcome of interest for the treated group (JSY = 1) and the
Effect of JSY on Childhood Immunization and Other Outcomes
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findings as average effects across all JSY recipients. We repeated
analyses separately for LPS and HPS. Following prior guidance
suggesting that survey weights are not needed for matched
analyses if the model is correctly specified,[28] we did not include
survey weights in the main analysis, but we conducted a sensitivity
analysis that did include survey weights. The propensity score
matching was done in R (version 2.12.1) and all other analyses
were conducted in Stata (version 12).
Sensitivity analyses
We tested various alternative model specifications such as
including child’s gender and an indicator for LPS (alone and
interacted with the treatment effect) as covariates, running the
analysis with district-level fixed effects, and accounting for
calendar time heterogeniety. We carried out an analysis including
ever-married women 45–49 years of age. For immunization
outcomes, we replicated the coarsened-exact matching analysis
carried out by Lim and colleagues using the same coarsened
matching covariates as the authors.[17] For these outcomes, we
also re-ran the analyses restricted to children born within the last
12 months before the survey. In addition, we reran the analyses
separately for individuals with immunization cards and those
missing immunization cards, to investigate any potential differ-
ences in the effect of JSY between the two groups. Roughly 43% of
individuals had immunization cards for their children that they
were able to produce to the interviewers. Of the remaining 57% of
the sample, just over half (54%) reported having an immunization
card but were unable to show it to the interviewers, and the
remaining group did not have a card. We grouped together all
families that were unable to show an immunization card to the
survey interviewers (and thus relied on parental recall) and
considered them as those with missing immunization cards.
Finally, we re-ran the propensity score matching and logistic
regressions separately for women who delivered in a health facility,
and women who delivered elsewhere. While susceptible to
endogeneity bias, this stratified analysis allows for the control of
unobserved heterogeneity between women who delivered in
facilities and those who didn’t, and corrects for biases related to
the potential reverse causality between institutional delivery and
receipt of the cash transfer.[18]
Results
Mean immunization rates among our sample population
(children aged 12 to 23 months that were the most recent births
of women 15 to 44 years of age) are shown in Table 1. Nearly
95% of children had been vaccinated at least once against polio,
while only 71% of children had received a measles vaccine. Large
drops in coverage rates between the first and third recommended
doses were seen for both polio (23 percentage point drop) and
DPT (18 percentage point drop) vaccines. At the national level,
54% of children aged 12 to 23 months were fully vaccinated; less
than 5% of children had received no vaccine.
National-level means mask substantial variation in immuniza-
tion rates across geographic and socioeconomic strata of the
country. Figure 1 shows district-level variations in the proportion
of children aged 12 to 23 months who are fully vaccinated. States
with bolded outlines are LPS. As can be seen from this figure,
these LPS, along with the Northeast states, both of which were
priorities of JSY, have consistently lower immunization rates
compared to HPS. (Figure 1)
Selected results from the multivariate logistic regression on
matched samples are shown in Table 2. (Full regression results in
Table S2) Computed predicted probabilities show that receipt of
financial assistance from JSY led to a significant increase in
immunization rates of several percentage points among children
aged 12–23 months, across all vaccines considered. (Table 3)
With the exception of hepatitis B, which was borderline significant
at the 95% confidence level in the base case analysis, the smallest
effect of JSY (3.1 percentage points) was on the first dose of polio
vaccine, which also had the highest national coverage rate (94%).
(Table 1) The largest effect sizes (7.8 percentage points) were seen
on the coverage of polio zero and DPT3, which have much lower
national level coverage rates. (Table 1) For most vaccines, JSY
payments resulted in a 3 to 8 percentage point increase in
coverage. Maternal receipt of cash payments from JSY led to an
increase in 9.1 percentage points in the proportion of fully
vaccinated children, and a reduction of 3.2 percentage points in
the proportion of children who had not received a single vaccine.
A conservative definition of vaccine status, which considered
children with missing or ‘‘Don’t know’’ responses as not having
been vaccinated, produced the same results across all vaccines,
with the exception of polio at birth. For this outcome, which had
high proportion (8%) of ‘‘Don’t know’’ responses, particularly
from caregivers asked whether their child had received their first
polio vaccine within 2 weeks of birth, the estimated JSY treatment
effect was lower than that found using the base case vaccine status
definitions.
National-level means for all other reproductive and child health
indicators, including postnatal check-up rates, breastfeeding
behavior, and IMCI-related indicators are shown Table 4.
Nearly half of all mothers and their newborns received a postnatal
check-up following delivery. While the majority of mothers (82%)
breastfed colostrum to their baby, less than half (41%) started
breastfeeding within one hour of birth. Only 37% of infants born
within the last 12 months prior to the survey were exclusively
breastfed for 6 months (or were still currently being breastfed). The
majority of caregivers sought advice or treatment if their children
had diarrhea, fever, or symptoms of pneumonia.
Receipt of financial assistance from JSY had a large and
significant positive effect of 26–27 percentage points on postnatal
check-ups among mothers and newborns. (Table 5) JSY also had
a positive effect on breastfeeding behaviors immediately following
childbirth. Of 100 women who received cash assistance from JSY,
an additional 7 women began breastfeeding within an hour after
delivery, and an additional 4 women breastfed their baby
colostrum. No significant effect was found from maternal receipt
of financial assistance from JSY on exclusive breastfeeding or care-
seeking behaviors for sick children.
Results were consistent across an array of different model
specifications. Hepatitis B was the only exception, for which the
treatment effect ceased to remain significant across several
robustness checks. Effect estimates were insensitive to the use of
survey weights and calendar time of interview fixed effects. Child’s
gender was found to have a small but significant association with
postnatal check-ups, seeking advice or treatment for diarrhea or
pneumonia, and some vaccination outcomes, with male children
slightly more likely to be involved in these healthy behaviors. Being
a LPS was negatively associated with all reproductive and child
health indicators considered, controlling for individual-level
covariates, and this association was significant across all outcomes
except care-seeking behaviors. When including interaction effects
between LPS and JSY, the treatment effect of JSY ceased to
remain significant for some immunization outcomes (polio zero,
first dose of polio, no vaccine) and the early breastfeeding
outcomes. For these outcomes, the differential effect of the
program in LPS remained significant. Similarly to findings by
Effect of JSY on Childhood Immunization and Other Outcomes
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Mean 95% CI, upper 95% CI, lower
BCG 87.5% 87.2% 87.8%
Polio at birth 58.1% 57.6% 58.5%
Polio 1 93.8% 93.5% 94.0%
Polio 3 70.9% 70.4% 71.3%
DPT 1 83.9% 83.6% 84.2%
DPT 3 66.0% 65.6% 66.4%
Measles 70.9% 70.5% 71.3%
Hepatitis B 29.6% 29.2% 30.1%
Fully vaccinated child* 54.1% 53.7% 54.6%
No vaccine 4.6% 4.5% 4.8%
*A fully vaccinated child was defined as a child who had received one dose of BCG vaccine, 3 doses of DPT and polio vaccines (not including polio at birth), and one
dose of measles vaccine. [IIPS 2010]
doi:10.1371/journal.pone.0109311.t001
Figure 1. Percent of children 12–23 months at the time of the survey who were fully vaccinated by district, for high and low
performing states, 2007–08.* *Among most recent births for women ages 15–44 years of age. A fully vaccinated child was defined as a child who
had received one dose of BCG vaccine, 3 doses of DPT and polio vaccines (not including polio at birth), and one dose of measles vaccine. [IIPS 2010]
Dark (bolded) outlines represent the ten low-performing states (LPS): Uttar Pradesh, Uttarakhand, Bihar, Jharkhand, Madhya Pradesh, Chhattisgarh,
Assam, Rajasthan, Orissa, and Jammu and Kashmir. Districts with no data are in white.
doi:10.1371/journal.pone.0109311.g001
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immunization outcomes (Figure 2) and all check-up and
breastfeeding behavior outcomes considered.[17] Including dis-
trict-level fixed effects had minimal impact on results for most
vaccine outcomes. The estimated treatment effect had overlapping
95% confidence intervals for all but the ‘‘no vaccine’’ outcome, for
which the effect size was larger (26.9% vs 23.2%) compared to
the base case. Results from the coarsened exact matching method
were similar to the base case findings. (Figure S2)
In the sensitivity analysis restricted to most recent births within
the last 12 months prior to the survey, larger effects of JSY were
found among vaccine outcomes that occur close to the time of
birth (including no vaccine), while smaller effects were found for
measles and the proportion of fully vaccinated children.
(Figure 3) Because most children in this sample population are
under 12 months of age, their vaccine status would be subject to a
censoring effect. This effect would be greatest for vaccine
outcomes that occur closer to 1 year of age (measles, third dose
of polio and DPT, fully vaccinated). Results from the analysis
stratified by possession of an immunization card showed important
differences in the effect of JSY across both groups. Receipt of
financial incentives from JSY had a small (# 3%) or no effect
among those with vaccination cards while the effect size was much
larger than the base case results for the group missing vaccination
cards, for nearly all immunization outcomes. (Figure 4) For all
outcomes, mean immunization levels were consistently higher in
the group with vaccination cards. (Table S3) Finally, a stratified
analysis by delivery location generally resulted in lower treatment
effect sizes, particularly among analyses restricted to women
delivering in a health facility. (Figure 5) Most results remained
significant at the 95% confidence level despite much wider
confidence intervals, especially among out-of-facility deliveries that
involved smaller sample sizes.
Table 3. National level results from logistic regression of JSY effects on immunization outcomes among most recent births 12–23
months prior to survey to women 15–44 years.
Estimated JSY treatment effect N
Point est. 95% CI, lower 95% CI, upper
BCG 4.9% 4.0% 5.8% 12,520
Polio at birth 7.8% 6.1% 9.4% 12,303
Polio 1 3.1% 2.2% 4.0% 12,526
Polio 3 6.3% 5.0% 7.6% 12,026
DPT1 5.6% 4.6% 6.6% 12,436
DPT3 7.8% 6.3% 9.3% 12,188
Measles 5.9% 4.4% 7.3% 12,438
Hepatitis B 1.8% 0.3% 3.3% 11,907
Fully Vaccinated* 9.1% 7.5% 10.7% 12,592
No vaccine 23.2% 24.0% 22.4% 12,177
*A fully vaccinated child was defined as a child who had received one dose of BCG vaccine, 3 doses of DPT and polio vaccines (not including polio at birth), and one
dose of measles vaccine. [IIPS 2010]
doi:10.1371/journal.pone.0109311.t003
Table 4. National level child health outcomes relating to the most recent births to women 15–44 years born within the last 12
months prior to the survey.
Mean 95% CI, upper 95% CI, lower
Post-natal care
Woman, within 48 hr after delivery 49.9% 49.4% 50.3%
Newborn, within 24 hr after birth 50.6% 50.1% 51.0%
Breastfeeding behavior
Early initiation of breastfeeding* 41.1% 40.7% 41.5%
Breastfed colostrum to child 81.2% 80.9% 81.5%
Excl. breastfed for 6 months or continuing 37.0% 36.6% 37.4%
IMCI** indicators
Sought advice or treatment for diarrhea 68.5% 67.5% 69.5%
Sought advice or treatment for symptoms of pneumonia*** or fever 73.1% 72.3% 73.8%
*Defined as started breastfeeding within 1 hour of birth.
**Integrated management of childhood illnesses (IMCI).
***Pneumonia defined as cough plus fast breathing.
doi:10.1371/journal.pone.0109311.t004
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Our results indicate that India’s conditional cash transfer
program led to improvements in reproductive and child health
indicators in India, in particular childhood immunization
outcomes. Receipt of cash assistance for delivery resulted in
increased immunization rates, by several percentage points, across
the full range of vaccines considered. The smallest effect was seen
in a single dose of polio vaccine, which had a coverage rate of
nearly 95%. Vaccines with the lowest coverage rates (polio at
birth, three doses of DPT and polio, and measles) had higher
treatment effects, ranging from six to eight percentage points
increase. The treatment effect of JSY on the proportion of children
12 to 23 months of age who were fully vaccinated was an increase
of nine percentage points. In other words, for every 100 children
whose mother received financial assistance from JSY for delivery,
nine additional children were fully vaccinated. The effect size for
hepatitis B immunization was small, and ceased to remain
significant across robustness checks. It is worth noting that
hepatitis B vaccine was introduced into select states and districts
as a pilot in 2002–03, and only expanded to the rest of the country
in 2010–11.[9] Although women received cash assistance from
JSY at the time of delivery, as opposed to when their child was
vaccinated, the effects on immunizations were still found to be
Table 5. National level results from logistic regression of JSY effects on child health outcomes among most recent births to
women 15–44 years born within the last 12 months prior to the survey.
Estimated JSY treatment effect N
Point est. 95% CI, lower 95% CI, upper
Post-natal care
Woman, within 48 hr after delivery 24.8% 22.9% 26.7% 24,258
Newborn, within 24 hr after birth 25.7% 23.9% 27.4% 23,924
Breastfeeding behavior
Early initiation of breastfeeding* 6.8% 5.3% 8.3% 23,923
Breastfed colostrum to child 4.1% 3.0% 5.2% 23,917
Excl. breastfed for 6 months or continuing 21.0% 22.5% 0.4% 23,316
IMCI** indicators
Sought advice or treatment for diarrhea 3.7% 0.6% 6.9% 3,754
Sought advice or treatment for symptoms of pneumonia*** or fever 2.0% 20.2% 4.3% 5,799
*Defined as started breastfeeding within 1 hour of birth.
**Integrated management of childhood illnesses (IMCI).
doi:10.1371/journal.pone.0109311.t005
Figure 2. Estimated JSY treatment effect on childhood immunization outcomes among children 12 to 23 months of age, stratified
by LPS and HPS compared to national level results. Error bars represent 95% confidence intervals from regression estimates. * A fully
vaccinated child was defined as a child who had received one dose of BCG vaccine, 3 doses of DPT and polio vaccines (not including polio at birth),
and one dose of measles vaccine. [IIPS 2010]
doi:10.1371/journal.pone.0109311.g002
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had noted a significant effect of JSY on increasing antenatal care,
for which payment was not directly linked.[17]
There are several mechanisms through which cash transfers for
safe deliveries could impact on post-delivery reproductive and
child health indicators. One hypothesis is that increased interac-
tion with the health system as a result of JSY could have add-on
effects on health-related behaviors, particularly in the early post-
partum period. Although some have hypothesized that childhood
vaccinations occur too far after delivery for JSY to have an
impact,[18] several vaccinations, such as polio at birth and BCG,
take place at the time of childbirth or soon afterward. In addition,
the role of ASHAs involves promoting healthy reproductive
behaviors in the postpartum period including immunizations. In a
qualitative assessment carried out in eight LPS states, it was found
that although ASHAs were not provided additional incentives for
Figure 3. Estimated JSY treatment effect on childhood immunization outcomes: among children 12 to 23 months of age and
children under 12 months of age. Error bars represent 95% confidence intervals from regression estimates. * A fully vaccinated child was defined
as a child who had received one dose of BCG vaccine, 3 doses of DPT and polio vaccines (not including polio at birth), and one dose of measles
vaccine. [IIPS 2010]
doi:10.1371/journal.pone.0109311.g003
Figure 4. Estimated JSY treatment effect on childhood immunization outcomes among children 12 to 23 months of age: stratified
by possession of an immunization card. Error bars represent 95% confidence intervals from regression estimates. * A fully vaccinated child was
defined as a child who had received one dose of BCG vaccine, 3 doses of DPT and polio vaccines (not including polio at birth), and one dose of
measles vaccine. [IIPS 2010]
doi:10.1371/journal.pone.0109311.g004
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grassroots functionary.[19] In assessments carried out in 5 LPS,
the majority of ASHAs surveyed responded that they had provided
help or advice regarding breastfeeding practices and had
recommended childhood vaccinations to pregnant women and
recently delivered mothers.[15,29] A small study using records
from a tertiary level health center in the state of Orissa found that
‘at birth’ immunization (within 7 days of birth) increased
significantly following the implementation of JSY at the health
center.[30] In this study, ASHAs were cited by parents as the
primary motivator for immunization.
Still, it remains unclear just how much influence ASHAs have
on women’s behavior, especially decisions outside of choosing an
institutional delivery.[31] A few schemes started in the last two
years are expected to create more opportunities for ASHAs to
reach families during the postnatal period. In a scheme launched
in 2011 to strengthen home-based newborn care (HBNC), ASHAs
will be given incentives for providing home visits, with incentives
tied to BCG at birth and DPT and polio vaccines at 6 weeks.[32]
Another scheme exists for home delivery of contraceptives through
ASHAs, which will also help to increase contact during the
postnatal period.[33] Although incentives are not tied with
breastfeeding under this scheme, early breastfeeding is an
indicator for monitoring the HBNC scheme. Also, the training
package for ASHAs incorporates knowledge on immunization and
child nutrition. These approaches create more opportunities for
postnatal home visits by ASHAs, and may help to increase
immunization coverage and improve breastfeeding and comple-
mentary feeding practices in India.
The large impact of JSY on postnatal check-ups was expected
given JSY has previously been found to have led to a considerable
increase in institutional deliveries, but offers a useful validation of
the model and analysis. Perhaps more surprising was the minimal
effect on breastfeeding behaviors. Although an increase in several
percentage points was seen for early initiation of breastfeeding and
among children breastfed colostrum, no effect of cash assistance
for delivery was found on exclusive breastfeeding rates, even
though the proportion of children who were exclusively breastfed
for 6 months or currently being breastfed was well under 50%.
Qualitative evidence from surveys conducted in five LPS showed
that while ASHAs responded similarly to questions asking about
type of support or advice provided to pregnant women or recently
delivered mothers regarding immunizations and breastfeeding
behaviors, responses from recently-delivered women indicated less
advice received from ASHAs regarding breastfeeding behaviors
compared to immunizations.[15,29]
Results remained consistent across a range of model robustness
checks and sensitivity analyses. However, there are several
important limitations to consider. First, this analysis uses
propensity score matching on non-experimental data to make
causal claims. Doing so relies on the assumption that balancing
observations based on observable characteristics also balances
unobservables. This is a strong assumption that we were unable to
test. Although we have matched observations on a number of
individual and household level covariates that are likely to affect
receipt of financial assistance from JSY and the outcomes of
interest, our results are not robust against bias arising from
unobservable characteristics that are correlated with uptake of JSY
and study outcomes. Another main limitation of this analysis
concerns the differential timing and scale-up of JSY across the
country. While the program was officially established by the
federal government in April 2005, it took months (and in some
cases over a year) for JSY to be implemented and operationalized
across all states and UTs. During implementation of JSY, priority
was given to low performing states and the scheme was launched
early, while in several high performing states, ASHA recruitment
was slow and did not cover all areas during the first few years of
the scheme. Furthermore, differences in how the scheme was
institutionalized, including the way JSY was advertised, the
effectiveness of ASHAs, and the paperwork required for eligibility,
could have led to important differences in the effectiveness of JSY
across states and districts.
Figure 5. Estimated JSY treatment effect on childhood immunization outcomes among children 12 to 23 months of age: nationally
and stratified by delivery location. Error bars represent 95% confidence intervals from regression estimates. * A fully vaccinated child was
defined as a child who had received one dose of BCG vaccine, 3 doses of DPT and polio vaccines (not including polio at birth), and one dose of
measles vaccine. [IIPS 2010]
doi:10.1371/journal.pone.0109311.g005
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after JSY was established, and thus the effects may differ compared
to when implementation is complete and awareness of the scheme
is high across all states. Restricting the analysis to most recent
births in the last 12 months reduces issues related to the differential
introduction of JSY across districts and states: the earliest births
included in analyses restricted to this sample population occurred
in December 2006, over 1.5 years after JSY was established. To
avoid censored observations as a result of partially immunized
children, analyses on vaccination outcomes were restricted to
children 12 to 24 months of age. This sample thus included
children born seven months to over 2.5 years after JSY was
established. We explored including an indicator for LPS to
potentially reduce any additional bias due to heterogeneous timing
in the implementation of JSY across the country. While this was
only a partial remedy, any bias in the treatment effect of JSY will
be towards the null, and the estimates obtained will likely
underestimate the true effect of JSY. As an additional check, our
breastfeeding results are similar to those found by Mazumdar and
colleagues of a statistically significant effect of JSY of 7.4
percentage points on breastfeeding in the first hour, but no effect
on breastfeeding behavior within 24 hours.[18] Their analysis
controlled for time invariant district-level unobservables and
accounted for heterogeneity in the timing of the introduction of
JSY across the country.[18]
The validity of our results is limited by the quality of the
household survey data, in particular the reliability of immuniza-
tion card data and maternal recall and self-reporting on their
child’s vaccination status. The subsample analysis shows that these
two groups differ significantly with respect to the effect of JSY on
childhood immunization outcomes. Maternal receipt of financial
incentives from JSY had little to no effect among the group with
immunization cards. There are several possible explanations for
this. First, it is likely that these two groups are systematically
different from each other in ways that are not controlled for in the
analysis. Second, immunization rates among the group relying on
maternal recall may be over- or underestimated. It is also possible
that those relying on maternal recall may be more likely to report
receiving specific vaccinations linked to the JSY program even if
their child had not received the vaccine. In this case, the effect of
the program would be overestimated. On the other hand,
childhood immunization rates are much higher among those with
immunization cards, with little room for increased coverage for
some vaccine outcomes.
We also did not consider the timing of vaccines and whether
vaccines were received at the appropriate time to ensure full
protection against disease.[34] Interestingly, restricting the sample
to children born in the last 12 months prior to the survey generally
resulted in larger treatment effects among immunization outcomes
that occur early in life, possibly indicating improved timing of
vaccines with JSY.
In an analysis stratified by in-facility delivery, we attempted to
control for unobserved heterogeneity between women who
delivered in facilities and those who did not. While treatment
effects are lower in both stratified analyses, we still find significant
effects of financial receipt of JSY on immunization outcomes. The
biggest drops in effect size were among women delivering in a
health facility, as would be expected, given the pathway of
increased immunization as a result of interaction with a health
facility is not being captured.
The evolution of JSY post 2008 was rapid. The program has
expanded considerably since it began in 2005, reaching over 10
million beneficiaries in 2011-2012 (up from 3 million in 2006–
2007, and 7 million in 2007–2008).[35] Our results must therefore
be interpreted in light of the current shape of the program, as well
as other related programs that have more recently been
implemented. With over 870,000 ASHAs currently engaged in
communities in all states, and along with the recent home based
newborn care scheme, an even bigger emphasis may be placed on
childhood immunizations. Another new initiative launched in
2011, Janani Shishu Suraksha Karyakaram (JSSK), provides free
and cashless services for delivery care in public institutions,
including cesarean section, and postnatal care for sick newborns,
and is being further expanded to include free antenatal and
postnatal care for all infants.[36]
Despite the limitations, our findings have a number of
promising implications. Increased childhood vaccination coverage
as a result of JSY translates into protection from disease, disability
and death among many children who would not have previously
been immunized. Further insights gained from this analysis are the
existence of untapped opportunities to piggyback additional
benefits on to this program, such as improvements in breastfeeding
behaviors, IMCI indicators, and nutrition and sanitation out-
comes.
Vaccination is one of the most cost-effective ways to prevent
disease and disability and improve childhood survival. However
from an operational standpoint, increasing the coverage of
immunizations can be difficult and costly. A pilot project
conducted in Moradabad district of Uttar Pradesh from mid-
2006 to early 2007 that sought to identify and vaccinate all
newborns with oral polio vaccine within 72 hours of birth had
disappointing results.[37] Researchers found the program to have
high expansion costs and marginal impacts. One of the major
insights from that study was that no mechanism was in place to
routinely identify newborns, especially for deliveries that occur
outside of health facilities.[37]
Janani Suraksha Yojana is one of the largest cash transfer
programs in the world,[36] and offers a potential new opportunity
to reach newborns and infants that previously would not have had
much interaction with the health system. At an expenditure that
increased from 383 million Rs. (,$6.3 million) in the 2004–2005
financial year to 16 billion Rs. (,$266 million in 2011–2012),[38]
policy makers must be aware of the financial implications of the
program. Although we have not attempted to estimate the cost-
effectiveness of India’s JSY program here, this is an important area
of further research.[21]
The structuring of financial incentives also requires careful
consideration. Early assessments of JSY point to delays in receipt
of payments by mothers and ASHAs, and in some cases, informal
payments were required to receive the cash.[15,39] Grievances by
ASHAs regarding the uneven balance between expected workload
and payment received for some services (including immunizations)
could indicate the need for a revision of the payment structure.[40]
The home-based newborn care and home delivery of contracep-
tives schemes will help to increase the incentives ASHAs receive
every month and could help allay the grievances of ASHAs.
Recent evidence of corruption in India’s most populous state,
Uttar Pradesh, which has some of the worst health indicators and
therefore was also the state allocated the largest budget for JSY,
warns of the need for systems in place to monitor and evaluate the
scheme carefully at all levels of administration.[41]
There are important health systems issues that could jeopardize
the success of the program. Shortages of human resources and
absence of health personnel in facilities are problematic, as these
workers are needed to administer vaccines. There is also
substantial evidence of poor quality of infrastructure, including
limited cold chain capacity of many states for accommodating
even routine UIP vaccines, and limited awareness in some areas
Effect of JSY on Childhood Immunization and Other Outcomes
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monitoring of vaccine coverage is critical, and additional health
systems research to identify and target poor management, and lack
of human resources, infrastructure and supplies is necessary.
Behavioral research into the role of ASHAs and their influence on
reproductive health behaviors is also a priority. Finally, given the
persistent health and coverage inequalities across geographic areas
socioeconomic groups in India, it will be essential to ensure the
program reaches population groups that were initially targeted as
having the highest need.
In December 2010, a Decade of Vaccines Collaboration was
declared by a partnership of international agencies working in
immunization.[7] While India is still far off from achieving 90%
coverage of DPT3, one of the goals of the Global Immunization
Vision and Strategy, it is evidently progressing in the right
direction.[7] With one fifth of all children under-five in the
world,[43] even a few percentage points increase in childhood
immunization rates could be of global health significance. India
has achieved success in its polio eradication efforts, with 2011
being the first year India was declared polio free; policy makers
must sustain efforts to preserve these successes.
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